Strength in the pharmaceutical major’s oncology business offset weak China sales, but the company has warned of a potential ...

By Michael Erman and Sriparna Roy (Reuters) -Bristol Myers Squibb on Thursday said its 2025 revenue would fall more sharply ...

Bristol Myers Squibb on Thursday posted better-than-expected fourth quarter earnings, but said its 2025 revenue would fall ...

Ceigall India experienced a 9.46% decrease in consolidated profit for the December quarter, totaling Rs 70.8 crore, despite ...

Alphabet shares fell more than 9% in after-hours trading Tuesday after the company reported fourth-quarter results that ...

Alphabet said on Tuesday it will spend $75 billion on its AI buildout this year, 29% more than Wall Street expected, and ...

Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

Advanced Micro Devices shares fell on Wednesday after the chipmaker under-delivered on Wall Street’s estimates for its ...

Healthpeak Properties reported mixed earnings and revenue data in Q4 2024, driven by strategic mergers and strong leasing ...

Regeneron's Q4 earnings report shows revenue growth, stable EYLEA sales, dividend announcement, and impressive growth for ...

Shares of Uber Technologies Inc. dropped 8% in trading today after the company reported better-than-anticipated revenue for ...

Milwaukee-based Harley-Davidson Inc. saw its fourth quarter revenue drop by $365 million, leaving its full year of sales down ...